Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kewaunee Scientific (KEQU) Cash from Operations (2016 - 2026)

Kewaunee Scientific (KEQU) has 16 years of Cash from Operations data on record, last reported at 4265000.0 in Q4 2025.

  • For Q4 2025, Cash from Operations fell 150.56% year-over-year to 4265000.0; the TTM value through Oct 2025 reached 8667000.0, down 52.61%, while the annual FY2025 figure was 14783000.0, 24.44% down from the prior year.
  • Cash from Operations reached 4265000.0 in Q4 2025 per KEQU's latest filing, down from 5791000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 9500000.0 in Q1 2024 and bottomed at 6798000.0 in Q2 2022.
  • Average Cash from Operations over 5 years is 1281300.0, with a median of 252000.0 recorded in 2023.
  • The widest YoY moves for Cash from Operations: up 3050.43% in 2021, down 387.78% in 2021.
  • A 5-year view of Cash from Operations shows it stood at 4295000.0 in 2021, then increased by 0.56% to 4271000.0 in 2022, then skyrocketed by 117.49% to 747000.0 in 2023, then surged by 1029.32% to 8436000.0 in 2024, then plummeted by 150.56% to 4265000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Operations were 4265000.0 in Q4 2025, 5791000.0 in Q3 2025, and 9407000.0 in Q2 2025.